Your session is about to expire
← Back to Search
ICS/LABA for Asthma Nonadherence
Study Summary
This trial seeks to assess why people don't take their inhalers & test a new approach to reduce asthma hospitalization due to non-adherence.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have completed less than 70% of the required texts after screening.My asthma is partially controlled, with an ACT score between 12 and 20.You have not been taking your prescribed asthma medication regularly, missing at least 2 refills in the past 6 months or scoring less than 4.5 on a medication adherence scale.I have been diagnosed with persistent asthma and have been on a prescribed asthma treatment plan for at least 6 months.I have a lung condition like COPD, cystic fibrosis, or alpha 1 anti-trypsin deficiency.I am unwilling or unable to use or pay for a specific inhaler compatible with the Adherium sensor.I am currently using a biologic or experimental treatment for asthma.I am between 18 and 75 years old.I was admitted to the ICU for asthma in the past year.I understand the study and agree to participate.
- Group 1: As needed inhaled corticosteroid and long-acting beta-agonist
- Group 2: Standard therapy: maintenance inhaled corticosteroid and as needed short-acting beta-agonist
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the upper age limit for this experiment beyond eighty-five years old?
"The target demographic for this research is children aged 12-17."
What type of participants would be best suited to enroll in this medical study?
"The eligibility criteria for this clinical trial is composed of participants aged 12 to 17 with a history of medication nonadherence. The research team hopes to recruit approximately 40 individuals that meet these requirements."
What is the projected enrollment size of this research initiative?
"Affirmative. According to clinicaltrials.gov, this medical trial was posted on April 1st 2022 and is open for enrollment as of January 9th 2023. The study aims to recruit 40 patients from one specific site location."
Is there any availability for applicants to join this clinical trial?
"Clinicaltrials.gov reveals that this study is actively seeking participants; it was first uploaded to the website on April 1st 2022, and its details were most recently modified on January 9th 2023."
Share this study with friends
Copy Link
Messenger